Ikarian Capital’s BELLUS Health Inc. BLU Stock Holding History

Ikarian Capital’s Portfolio BLU Stock Details BLU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-885,334	Closed	-$6.37M	–	166
2023 Q1	$6.37M	Hold	885,334	–	–	1.45%	23
2022 Q4	$7.28M	Buy	885,334 +35,200	+4%	+$328K	1.76%	19
2022 Q3	$8.98M	Sell	850,134 -168,193	-17%	-$1.79M	1.79%	18
2022 Q2	$9.41M	Buy	1,018,327 +105,000	+11%	+$859K	1.72%	18
2022 Q1	$6.28M	Buy	913,327 +863,327	+1,727%	+$5.56M	0.83%	36
2021 Q4	$402K	Sell	50,000 -694,616	-93%	-$4.61M	0.06%	137
2021 Q3	$4.57M	Sell	744,616 -265,929	-26%	-$1.01M	0.32%	71
2021 Q2	$3.14M	Buy	1,010,545 +610,545	+153%	+$2.33M	0.25%	95
2021 Q1	$1.54M	Buy	400,000 +300,000	+300%	+$1.14M	0.05%	218
2020 Q4	$306K	Hold	100,000	–	–	0.01%	205
2020 Q3	$227K	Buy	+100,000	New	+$284K	0.02%	152
2020 Q2	–	Sell	-63,721	Closed	-$891K	–	213
2020 Q1	$891K	Hold	63,721	–	–	0.07%	124
2019 Q4	$625K	Buy	+63,721	New	+$436K	0.1%	88

Other funds holding BLU

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

VAM

Vazirani Asset Management New York $43.4M AUM 84.05% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Canada Life Winnipeg, Manitoba, Canada $55.8B AUM 26.04% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.32B AUM 51.82% 1-Year Est. Return

Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return

Ikarian Capital's BLU Position: Q2 2023 in Review

Ikarian Capital sold out of BELLUS Health Inc. (BLU) in Q2 2023, closing a stake of 885,334 shares — an estimated $6.37M sold.

Ikarian Capital first reported a position in BLU in Q4 2019 and held it in 13 quarters. The position peaked at $9.41M in Q2 2022. 11 funds tracked by Wall St. Rank hold BLU as of Q2 2023.

Ikarian Capital reported no remaining BELLUS Health Inc. position as of Q2 2023 after selling out during the quarter.
Ikarian Capital sold 885,334 BELLUS Health Inc. shares in Q2 2023, an estimated $6.37M.
Ikarian Capital first reported a position in BELLUS Health Inc. in Q4 2019 and held it in 13 quarters.
Ikarian Capital's BELLUS Health Inc. position peaked at $9.41M in Q2 2022.
11 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q2 2023.

Based on Ikarian Capital's 13F filing for Q2 2023, filed 14 Aug 2023.